These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32593202)

  • 1. Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID-19 pneumonia.
    Chopra J; Hiew HJ; Cumpstey A; Cagampang F; Jenner MW; Dushianthan A
    Br J Haematol; 2020 Aug; 190(4):e195-e198. PubMed ID: 32593202
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrotic Lung Toxicity Induced by Hydroxycarbamide.
    Bargagli E; Palazzi M; Perri F; Torricelli E; Rosi E; Bindi A; Pistolesi M; Voltolini L
    In Vivo; 2017; 31(6):1221-1223. PubMed ID: 29102950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia.
    Otrock ZK; Taher AT; Mahfouz RA; Makarem JA; Shamseddine AI
    Am J Hematol; 2006 Mar; 81(3):220-1. PubMed ID: 16493602
    [No Abstract]   [Full Text] [Related]  

  • 4. Haematoidin in chronic myelomonocytic leukaemia during irregular treatment with hydroxycarbamide.
    Zhang X; Tao C; Long F
    Br J Haematol; 2024 May; 204(5):1569-1570. PubMed ID: 38528621
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
    Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
    Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia.
    Buresh A; Perentesis J; Rimsza L; Kurtin S; Heaton R; Sugrue M; List A
    Leukemia; 2005 Feb; 19(2):308-10. PubMed ID: 15538404
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case.
    Imai H; Matsumura N; Yamazaki Y; Kanayama Y; Masuda T; Kuwako T; Kamide Y; Tomizawa T; Matsumoto S; Mitsui T; Kaira K; Ono A; Koga Y; Shibusawa N; Sunaga N; Hisada T; Yokoo H; Yamada M
    Intern Med; 2015; 54(24):3171-6. PubMed ID: 26666606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic myelomonocytic leukemia with pleural effusion as the first clinical sign].
    Yamazaki E; Kanai M; Sakai R; Sakamoto H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Mar; 46(3):217-9. PubMed ID: 16447718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
    Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A
    J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19.
    Sharif S; Rochwerg B
    Ann Intern Med; 2021 Feb; 174(2):JC16. PubMed ID: 33524280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.
    Barrett CD; Moore HB; Moore EE; Wang J; Hajizadeh N; Biffl WL; Lottenberg L; Patel PR; Truitt MS; McIntyre RC; Bull TM; Ammons LA; Ghasabyan A; Chandler J; Douglas IS; Schmidt EP; Moore PK; Wright FL; Ramdeo R; Borrego R; Rueda M; Dhupa A; McCaul DS; Dandan T; Sarkar PK; Khan B; Sreevidya C; McDaniel C; Grossman Verner HM; Pearcy C; Anez-Bustillos L; Baedorf-Kassis EN; Jhunjhunwala R; Shaefi S; Capers K; Banner-Goodspeed V; Talmor DS; Sauaia A; Yaffe MB
    Chest; 2022 Mar; 161(3):710-727. PubMed ID: 34592318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A favourable effect of recombinant human erythropoietin in three cases of leukaemic transformation from chronic myelomonocytic leukaemia.
    Uziel L; Fabrizi I; Zighetti ML; Carpani G; Rosti A; Moroni GA; Marmont A
    Br J Haematol; 1992 Feb; 80(2):260-2. PubMed ID: 1550789
    [No Abstract]   [Full Text] [Related]  

  • 14. An open label trial of anakinra to prevent respiratory failure in COVID-19.
    Kyriazopoulou E; Panagopoulos P; Metallidis S; Dalekos GN; Poulakou G; Gatselis N; Karakike E; Saridaki M; Loli G; Stefos A; Prasianaki D; Georgiadou S; Tsachouridou O; Petrakis V; Tsiakos K; Kosmidou M; Lygoura V; Dareioti M; Milionis H; Papanikolaou IC; Akinosoglou K; Myrodia DM; Gravvani A; Stamou A; Gkavogianni T; Katrini K; Marantos T; Trontzas IP; Syrigos K; Chatzis L; Chatzis S; Vechlidis N; Avgoustou C; Chalvatzis S; Kyprianou M; van der Meer JW; Eugen-Olsen J; Netea MG; Giamarellos-Bourboulis EJ
    Elife; 2021 Mar; 10():. PubMed ID: 33682678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.
    Michot JM; Albiges L; Chaput N; Saada V; Pommeret F; Griscelli F; Balleyguier C; Besse B; Marabelle A; Netzer F; Merad M; Robert C; Barlesi F; Gachot B; Stoclin A
    Ann Oncol; 2020 Jul; 31(7):961-964. PubMed ID: 32247642
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic Myelomonocytic Leukemia with Myelofibrosis Resulting in Sudden Massive Pleural Effusion during Cytoreductive Therapy with Hydroxycarbamide].
    Sunami Y; Gotoh A; Watanabe N; Edahiro Y; Hamano Y; Harada H; Komatsu N
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1223-1226. PubMed ID: 27760943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure.
    Nagaoka K; Kawasuji H; Murai Y; Kaneda M; Ueno A; Miyajima Y; Fukui Y; Morinaga Y; Yamamoto Y
    Front Immunol; 2022; 13():844304. PubMed ID: 35237279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
    Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
    Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
    Berton AM; Prencipe N; Giordano R; Ghigo E; Grottoli S
    J Endocrinol Invest; 2021 Apr; 44(4):873-875. PubMed ID: 32514902
    [No Abstract]   [Full Text] [Related]  

  • 20. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19.
    Matthews L; Baker L; Ferrari M; Sanchez W; Pappachan J; Grocott MP; Dushianthan A;
    J Intensive Care Med; 2022 Aug; 37(8):1101-1111. PubMed ID: 35369798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.